SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype
暂无分享,去创建一个
L. Staudt | A. Rosenwald | D. Weisenburger | K. Fu | R. Gascoyne | D. de Jong | A. López-Guillermo | E. Campo | L. Rimsza | G. Ott | A. Valera | P. Jares | S. Dave | E. Jaffe | J. Delabie | D. Colomer | C. Royo | R. Braziel | E. Hartmann | S. Chuang | C. Baró | A. Mozos | C. Ruíz-Marcellán | F. Solè | Alexandra Valera
[1] E. Campo,et al. Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques , 2008, Genes, chromosomes & cancer.
[2] B. Sander,et al. The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival , 2008, British journal of haematology.
[3] A. Rosenwald,et al. Delineation of distinct tumour profiles in mantle cell lymphoma by detailed cytogenetic, interphase genetic and morphological analysis , 2008, British journal of haematology.
[4] M. Du,et al. Mantle cell lymphoma with aberrant expression of CD10 , 2008, Histopathology.
[5] H. Pospíšilová,et al. Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas. , 2008, Blood.
[6] E. Campo,et al. Secondary genomic alterations in non-Hodgkin’s lymphomas: tumor-specific profiles with impact on clinical behavior , 2008, Haematologica.
[7] H. Müller-Hermelink,et al. Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlations , 2008, Haematologica.
[8] L. de Leval,et al. Cyclin D1-negative mantle cell lymphoma with cryptic t(12;14)(p13;q32) and cyclin D2 overexpression. , 2008, Blood.
[9] Karin Jirström,et al. From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 28, 2013. For personal use only. , 2006 .
[10] E. Campo,et al. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics , 2007, Nature Reviews Cancer.
[11] L. Staudt,et al. Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] Juan F. García,et al. Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas. , 2007, Blood.
[13] E. Campo,et al. Mantle cell lymphoma in Taiwan: Clinicopathological and molecular study of 21 cases including one cyclin D1‐negative tumor expressing cyclin D2 , 2006, Pathology international.
[14] D. Weisenburger,et al. A chromosomal translocation in cyclin D1-negative/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus. , 2006, Blood.
[15] E. Campo,et al. Mantle cell lymphoma: from pathology and molecular pathogenesis to new therapeutic perspectives. , 2006, Haematologica.
[16] L. Staudt,et al. Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. , 2005, Blood.
[17] M. Zago,et al. Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K‐AKT, WNT and TGFβ signalling pathways , 2005, British journal of haematology.
[18] Juan F. García,et al. Aberrant Bcl6 Protein Expression in Mantle Cell Lymphoma , 2004, The American journal of surgical pathology.
[19] Kai Fu,et al. CD23 expression in mantle cell lymphoma: clinicopathologic features of 18 cases. , 2003, American journal of clinical pathology.
[20] L. Staudt,et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. , 2003, Cancer cell.
[21] F Solé,et al. Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies. , 2001, Blood.
[22] M. Seto,et al. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma. , 2000, Blood.
[23] A. López-Guillermo,et al. Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. , 1999, Blood.
[24] E. Campo,et al. Primary nodal marginal zone lymphomas of splenic and MALT type. , 1999, The American journal of surgical pathology.
[25] P. Isaacson,et al. Follicular Colonization in B‐Cell Lymphoma of Mucosa‐Associated Lymphoid Tissue , 1991, The American journal of surgical pathology.
[26] E. Jaffe,et al. Leukaemic phase of mantle zone (intermediate) lymphoma: its characterisation in 11 cases. , 1989, Journal of clinical pathology.